Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03015740
Title MGCD516 Combined With Nivolumab in Renal Cell Cancer (RCC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

clear cell renal cell carcinoma

renal cell carcinoma

Therapies

MGCD516 + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.